| |
| |
|
| Insider
Information: |
Scangos George A |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
937,662 |
|
|
Indirect Shares
|
3,762,360 |
|
|
| Direct
Value |
$30,756,665 |
|
|
|
Indirect Value
|
$5,121,576 |
|
|
| Total
Shares |
4,700,022 |
|
|
| Total
Value |
$35,878,242 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Exelixis Inc |
EXEL |
Director |
2020-05-18 |
714,717 |
2020-05-18 |
23,595 |
Premium* |
|
|
Anadys Pharmaceuticals Inc |
ANDS |
Director |
2008-08-26 |
33,188 |
2004-03-31 |
0 |
Premium* |
|
|
Biogen Idec Inc |
BIIB |
Chief Executive Office... |
2016-07-21 |
54,779 |
2016-07-21 |
10,756 |
Premium* |
|
|
Agilent Technologies Inc |
A |
Director |
2024-03-15 |
21,989 |
2024-03-15 |
14,450 |
Premium* |
|
|
Vir Biotechnology, Inc. |
VIR |
Director |
2024-02-26 |
112,989 |
2024-02-26 |
3,713,559 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
376 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 16
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2010-07-15 |
4 |
A |
$0.00 |
$0 |
D/D |
63,165 |
63,165 |
0 |
- |
|
| A |
Agilent Technologies Inc |
Director |
• • – |
2014-09-17 |
4 |
A |
$58.89 |
$138,568 |
D/D |
2,353 |
2,353 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2014-10-14 |
4 |
A |
$0.00 |
$0 |
D/D |
29,412 |
1,303,827 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2015-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
10,149 |
52,681 |
0 |
- |
|
| A |
Agilent Technologies Inc |
Director |
• • – |
2015-03-19 |
4 |
A |
$42.21 |
$181,967 |
D/D |
4,311 |
6,666 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2016-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
6,383 |
1,310,210 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2016-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
11,390 |
65,694 |
0 |
- |
|
| A |
Agilent Technologies Inc |
Director |
• • – |
2016-03-17 |
4 |
A |
$39.29 |
$184,820 |
D/D |
4,704 |
11,378 |
0 |
- |
|
| A |
Agilent Technologies Inc |
Director |
• • – |
2017-03-16 |
4 |
A |
$53.05 |
$205,091 |
D/D |
3,866 |
15,253 |
0 |
- |
|
| A |
Agilent Technologies Inc |
Director |
• • – |
2018-03-22 |
4 |
A |
$67.47 |
$291,070 |
D/D |
4,314 |
19,574 |
0 |
- |
|
| A |
Agilent Technologies Inc |
Director |
• • – |
2019-03-21 |
4 |
A |
$82.00 |
$334,385 |
D/D |
4,078 |
23,699 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
President and CEO |
• • – |
2020-04-14 |
4 |
A |
$29.56 |
$6,999,985 |
D/D |
236,806 |
4,713,559 |
0 |
- |
|
| A |
Agilent Technologies Inc |
Director |
• • – |
2020-04-17 |
4 |
A |
$73.01 |
$299,921 |
D/D |
4,108 |
27,887 |
0 |
- |
|
| A |
Agilent Technologies Inc |
Director |
• • – |
2020-08-03 |
4 |
A |
$93.91 |
$16,622 |
D/D |
177 |
28,112 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
President and CEO |
• • – |
2021-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
111,000 |
4,609,559 |
0 |
- |
|
| A |
Agilent Technologies Inc |
Director |
• • – |
2021-03-18 |
4 |
A |
$121.59 |
$344,838 |
D/D |
2,836 |
16,544 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
President and CEO |
• • – |
2022-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
111,000 |
223,989 |
0 |
- |
|
| A |
Agilent Technologies Inc |
Director |
• • – |
2022-03-17 |
4 |
A |
$136.82 |
$244,224 |
D/D |
1,785 |
18,420 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
President and CEO |
• • – |
2022-12-21 |
4 |
A |
$0.00 |
$0 |
I/I |
99,968 |
111,644 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
President and CEO |
• • – |
2023-01-18 |
4 |
A |
$0.00 |
$0 |
I/I |
64,930 |
179,930 |
0 |
- |
|
| A |
Agilent Technologies Inc |
Director |
– • – |
2023-03-16 |
4 |
A |
$136.82 |
$226,848 |
D/D |
1,658 |
20,185 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2023-09-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,750,000 |
1,918,489 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2023-09-15 |
4 |
A |
$0.00 |
$0 |
I/I |
1,750,000 |
1,750,000 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2023-10-17 |
4 |
A |
$0.00 |
$0 |
I/I |
3,500,000 |
1,750,000 |
0 |
- |
|
| A |
Agilent Technologies Inc |
Director |
• • – |
2024-03-15 |
4 |
A |
$147.48 |
$247,471 |
D/D |
1,678 |
21,989 |
0 |
- |
|
376 Records found
|
|
Page 1 of 16 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
